医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

3D Printing 2017, Additive Manufacturing Technology Exhibition, Brings You the Latest Information on the Cutting Edge 3D Printing Technologies, Design, Manufacturing and Materials Making

2017年01月31日 AM11:52
このエントリーをはてなブックマークに追加


 

TOKYO

JTB Communication Design, Inc. will be holding “3D Printing 2017” – the Cutting Edge 3D Printing Technologies exhibitions, now in its 3rd year – on February 15, 2017, at the Tokyo Big Sight convention center in Japan. 78 organizations (including over 37 first-time exhibitors) from 6 countries and regions are set to exhibit at the event in 102 booths (about 1,000sqm), demonstrating revolutionary and cutting edge core technologies. The concurrently held exhibitions, the total number of visitors to the event are expected to exceed 50,000.

 

3D Printing 2017 Additive Manufacturing Technology Exhibition

Date:   February 15-17, 2017, 10:00-17:00
Venue: Tokyo Big Sight (East Halls 6)
Organizer: JTB Communication Design
Nanotechnology Business Creation Initiative (NBCI)

View source version on businesswire.com: http://www.businesswire.com/news/home/20170130006262/en/

CONTACT

Secretariat of 3D Printing (c/o JTB Communication Design)
Ms. Mika
Seshima, +81-3-5657-0760
3dpritning@jtbcom.co.jp
http://www.3dprintingexpo.jp/index_en.html

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease